Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils

AUTOR(ES)

Johan, Katarzyna

FONTE

The National Academy of Sciences

RESUMO

Amyloid protein A (AA) amyloidosis is a consequence of some long-standing inflammatory conditions, and subsequently, an N-terminal fragment of the acute phase protein serum AA forms β-sheet fibrils that are deposited in different tissues. It is unknown why only some individuals develop AA amyloidosis. In the mouse model, AA amyloidosis develops after ≈25 days of inflammatory challenge. This lag phase can be shortened dramatically by administration of a small amount of amyloid extract containing an as yet undefined amyloid-enhancing factor. In the present study, we show that preformed amyloid-like fibrils made from short synthetic peptides corresponding to parts of several different amyloid fibril proteins exert amyloidogenic enhancing activity when given i.v. to mice at the induction of inflammation. We followed i.v. administered, radiolabeled, heterologous, synthetic fibrils to the lung and to the perifollicular area in the spleen and found that new AA–amyloid fibrils developed on these preformed fibrils. Our findings thus show that preformed, synthetic, amyloid-like fibrils have an in vivo nidus activity and that amyloid-enhancing activity may occur, at least in part, through this mechanism. Our findings also show that fibrils of a heterologous chemical nature exert amyloid-enhancing activity.

Documentos Relacionados

• Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.
• Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.
• Rationally designed mutations convert de novo amyloid-like fibrils into monomeric β-sheet proteins
• Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
• Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington’s disease pathology